Metabolic signatures of thymomas: potential biomarkers and treatment targets
European Journal of Cardio-Thoracic Surgery · 01.02.2024 · 65 (2)
DOI: 10.1093/ejcts/ezad394 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cardio-Thoracic Surgery, online erschienen am 27.11.2023. Verfasst von James W Miller und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA. Hauptthemen laut MEDLINE: Thymoma, Thymus Neoplasms, Cysts. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIDDK NIH HHS, NIH HHS.
Abstract (Originalsprache)
OBJECTIVES A study of tumour metabolic reprogramming has revealed disease biomarkers and avenues for therapeutic intervention. Metabolic reprogramming in thymoma is currently understudied and largely unknown. This study utilized metabolomics and isotope tracing with 13C-glucose to metabolically investigate thymomas, adjacent thymic tissue and benign thymic lesions. METHODS From 2017 to 2021, 20 patients with a suspected thymoma were recruited to this prospective Institutional Review Board approved clinical trial. At the time of surgery, 11 patients were infused with 13C-glucose, a stable, non-radioactive tracer which reports the flow of carbon through metabolic pathways. Samples were analysed by mass spectrometry to measure the abundance of >200 metabolites.13C enrichment was measured in patients who received 13C-glucose infusions. RESULTS Histological analysis showed that 9 patients had thymomas of diverse subtypes and 11 patients had benign cysts. In our metabolomic analysis, thymomas could be distinguished from both adjacent thymus tissue and benign lesions by metabolite abundances. Metabolites in pyrimidine biosynthesis and glycerophospholipid metabolism were differentially expressed across these tissues.13C-glucose infusions revealed differential labelling patterns in thymoma compared to benign cysts and normal thymus tissue. The lactate/3PG labelling ratio, a metabolic marker in aggressive lung tumours correlated with lactate uptake, was increased in thymomas (1.579) compared to normal thymus (0.945) and benign masses (0.807) (thymic tissue versus tumour P = 0.021, tumour versus benign P = 0.013). CONCLUSIONS We report metabolic biomarkers, including differential 13C labelling of metabolites from central metabolism, that distinguish thymomas from benign tissues. Altered glucose and lactate metabolism warrant further investigation and may provide novel therapeutic targets for thymoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
- Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, Dallas, TX, USA.
- Section of Hematology and Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA.
- Department of Cardiovascular and Thoracic Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA.
- Eugene McDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center, Dallas, TX, USA.
- Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, TX, USA.
ORCID-Profile: James W Miller
Förderung
- NCI NIH HHS
- NIDDK NIH HHS
- NIH HHS
- National Cancer Institute
- National Institutes of Health
Zitieren
APA
Miller, J. W., Faubert, B. M., Mathews, T. P., Waters, J. K., DeBerardinis, R. J., & Kernstine, K. H. (2024). Metabolic signatures of thymomas: potential biomarkers and treatment targets. European Journal of Cardio-Thoracic Surgery, 65(2). https://doi.org/10.1093/ejcts/ezad394
Vancouver
Miller JW, Faubert BM, Mathews TP, Waters JK, DeBerardinis RJ, Kernstine KH. Metabolic signatures of thymomas: potential biomarkers and treatment targets. European Journal of Cardio-Thoracic Surgery. 2024;65(2). doi:10.1093/ejcts/ezad394
BibTeX
@article{Miller2024,
author = {Miller, James W and Faubert, Brandon M and Mathews, Thomas P and Waters, John K and DeBerardinis, Ralph J and Kernstine, Kemp H},
title = {Metabolic signatures of thymomas: potential biomarkers and treatment targets},
journal = {European Journal of Cardio-Thoracic Surgery},
year = {2024},
volume = {65},
number = {2},
doi = {10.1093/ejcts/ezad394}
}
EUVIMED